bioRxiv Science⌕ Search

Biology subjects

Avila Cobos, F.

Publications and source records attributed to Avila Cobos, F..

5 recordsLinked to original sources

Effective methods for bulk RNA-Seq deconvolution using scnRNA-Seq transcriptomes

RNA profiling technologies at single-cell resolutions, including single-cell and single-nuclei RNA sequencing (scRNA-Seq and snRNA-Seq, scnRNA-Seq for short), can help characterize the composition of tissues and reveal cells that influence key functions in both healthy and disease tissues. However, the use of these technologies is operationally challenging because of high costs and stringent sample-collection requirements. Computational deconvolution methods that infer the composition of bulk-profiled samples using scnRNA-Seq-characterized cell types can broaden scnRNA-Seq applications, but their effectiveness remains controversial. We produced the first systematic evaluation of deconvolution methods on datasets with either known or scnRNA-Seq-estimated compositions. Our analyses revealed biases that are common to scnRNA-Seq 10X Genomics assays and illustrated the importance of accurate and properly controlled data preprocessing and method selection and optimization. Moreover, our results suggested that concurrent RNA-Seq and scnRNA-Seq profiles can help improve the accuracy of both scnRNA-Seq preprocessing and the deconvolution methods that employ them. Indeed, our proposed method, Single-cell RNA Quantity Informed Deconvolution (SQUID), combined RNA-Seq transformation and dampened weighted least-squares deconvolution approaches to consistently outperform other methods in predicting the composition of cell mixtures and tissue samples. Furthermore, our analysis suggested that only SQUID could identify outcomes-predictive cancer cell subclones in pediatric acute myeloid leukemia and neuroblastoma datasets, suggesting that deconvolution accuracy improvements are vital to enabling its applications in the life sciences.

systems biology↗

Performance of RNA purification kits and blood collection tubes in the Extracellular RNA Quality Control (exRNAQC) study

The use of blood-based extracellular RNA (cell-free RNA; exRNA) as clinical biomarker requires the implementation of a validated procedure for sample collection, processing, and profiling. So far, no study has systematically addressed the pre-analytical variables affecting transcriptome analysis of exRNAs. In the exRNAQC study, we evaluated ten blood collection tubes, three time intervals between blood draw and downstream processing, and eight RNA purification methods using the supplier-specified minimum and maximum biofluid input volumes. The impact of these pre-analytics on deep transcriptome profiling of both small and messenger RNA from healthy donors plasma or serum was assessed for each pre-analytical variable separately and for interactions between a selected set of pre-analytics, resulting in 456 extracellular transcriptomes. Making use of 189 synthetic spike-in RNAs, the processing and analysis workflow was controlled. When comparing blood collection tubes, so-called preservation tubes do not stabilize exRNA well, and result in variable RNA concentration and sensitivity (i.e., the number of detected RNAs) over time, as well as compromised reproducibility. We also document large differences in RNA purification kit performance in terms of sensitivity, reproducibility, and observed transcriptome complexity, and demonstrate interactions between specific blood collection tubes, purification kits and time intervals. Our results are summarized in 11 performance metrics that enable an informed selection of the most optimal sample processing workflow for a given experiment. In conclusion, we put forward robust quality control metrics for exRNA quantification methods with validated standard operating procedures (SOPs), representing paramount groundwork for future exRNA-based precision medicine applications.

genomics↗

Comprehensive benchmarking of computational deconvolution of transcriptomics data

Many computational methods to infer cell type proportions from bulk transcriptomics data have been developed. Attempts comparing these methods revealed that the choice of reference marker signatures is far more important than the method itself. However, a thorough evaluation of the combined impact of data transformation, pre-processing, marker selection, cell type composition and choice of methodology on the results is still lacking. Using different single-cell RNA-sequencing (scRNA-seq) datasets, we generated hundreds of pseudo-bulk mixtures to evaluate the combined impact of these factors on the deconvolution results. Along with methods to perform deconvolution of bulk RNA-seq data we also included five methods specifically designed to infer the cell type composition of bulk data using scRNA-seq data as reference. Both bulk and single-cell deconvolution methods perform best when applied to data in linear scale and the choice of normalization can have a dramatic impact on the performance of some, but not all methods. Overall, single-cell methods have comparable performance to the best performing bulk methods and bulk methods based on semi-supervised approaches showed higher error and lower correlation values between the computed and the expected proportions. Moreover, failure to include cell types in the reference that are present in a mixture always led to substantially worse results, regardless of any of the previous choices. Taken together, we provide a thorough evaluation of the combined impact of the different factors affecting the computational deconvolution task across different datasets and propose general guidelines to maximize its performance.

bioinformatics↗

Charting extracellular transcriptomes in The Human Biofluid RNA Atlas

Extracellular RNAs present in biofluids have emerged as potential biomarkers for disease. Where most studies focus on plasma or serum, other biofluids may contain more informative RNA molecules, depending on the type of disease. Here, we present an unprecedented atlas of messenger, circular and small RNA transcriptomes of a comprehensive collection of 20 different human biofluids. By means of synthetic spike-in controls, we compared RNA content across biofluids, revealing a more than 10 000-fold difference in RNA concentration. The circular RNA fraction is increased in nearly all biofluids compared to tissues. Each biofluid transcriptome is enriched for RNA molecules derived from specific tissues and cell types. In addition, a subset of biofluids, including stool, sweat, saliva and sputum, contains high levels of bacterial RNAs. Our atlas enables a more informed selection of the most relevant biofluid to monitor particular diseases. To verify the biomarker potential in these biofluids, four validation cohorts representing a broad spectrum of diseases were profiled, revealing numerous differential RNAs between case and control subjects. Taken together, our results reveal novel insights in the RNA content of human biofluids and may serve as a valuable resource for future biomarker studies. All spike-normalized data is publicly available in the R2 web portal and serve as a basis to further explore the RNA content in biofluids.

genomics↗

The RNA Atlas, a single nucleotide resolution map of the human transcriptome

The human transcriptome consists of various RNA biotypes including multiple types of non-coding RNAs (ncRNAs). Current ncRNA compendia remain incomplete partially because they are almost exclusively derived from the interrogation of small- and polyadenylated RNAs. Here, we present a more comprehensive atlas of the human transcriptome that is derived from matching polyA-, total-, and small-RNA profiles of a heterogeneous collection of nearly 300 human tissues and cell lines. We report on thousands of novel RNA species across all major RNA biotypes, including a hitherto poorly-cataloged class of non-polyadenylated single-exon long non-coding RNAs. In addition, we exploit intron abundance estimates from total RNA-sequencing to test and verify functional regulation by novel non-coding RNAs. Our study represents a substantial expansion of the current catalogue of human ncRNAs and their regulatory interactions. All data, analyses, and results are available in the R2 web portal and serve as a basis to further explore RNA biology and function.

genetics↗